The activity reflects routine post-exercise tax settlements and minimal open-market selling, not a signal of distress. Traders should monitor for any follow-up open-market sales beyond tax events, but this cluster does not suggest negative sentiment.
Price Chart
Executive Summary
United Therapeutics insiders executed a cluster of transactions over the past week, led by CEO Martine Rothblatt and other executives, primarily involving the exercise of derivative securities and tax-related share withholdings. The total value of open-market sales and tax withholding disposals exceeds $15.5 million, with the majority tied to non-cash exercises and tax settlements rather than discretionary selling.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt exercised over 100,000 derivative shares in multiple tranches, mostly at $0 cost, and sold 1,009 shares for $537,203 in open-market transactions.
- CFO James Edgemond and COO Michael Benkowitz each surrendered shares for tax withholding totaling $2.51M and $4.20M respectively after exercising derivatives.
- CEO Rothblatt surrendered 13,637 shares for tax withholding, valued at $7.31 million.
- Total value of share disposals (including tax withholding and open-market sales) exceeds $15.5 million over the 7-day period.
- Total open-market sales by insiders: $537,203 (CEO) + $24,008 (Director Malcolm) + $107,088 (Director Olian) = $668,299.
- Non-cash transactions (A, M, F) dominate the cluster, representing routine equity plan activity rather than active selling pressure.
Financial Impact
$15.5M in total share disposals over 7 days, including $668K in open-market sales and $14.8M in tax withholding from exercised options.
Risk Factors
- Large tax withholding events could signal upcoming reduced insider ownership if not offset by reinvestment.
- Perception risk: high-value share disposals may be misinterpreted as bearish despite being non-discretionary.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-UTHR-1773866106030 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access